Intersect ENT (XENT) Tops Q1 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AAPL
2. PLTR
3. VRTX
4. DOX
5. CRWD
6. CHKP
7. ON
8. HNGE
9. INSP
10. CVI

Go back to Intersect ENT (XENT) Tops Q1 EPS by 2c

Intersect ENT Reports First Quarter 2017 Results

May 2, 2017 4:05 PM EDT

MENLO PARK, Calif.--(BUSINESS WIRE)-- Intersect ENT, Inc. (NASDAQ: XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today reported financial results for the first quarter ended March 31, 2017.

First Quarter Financial Highlights

First quarter 2017 revenue was $20.5 million, a 23% increase over the first quarter 2016. First quarter 2017 gross margin was 86% compared to 81% in the first quarter 2016.

First Quarter Business Highlights

In February 2017, the company received approval from the... More